IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v595y2021i7869d10.1038_s41586-021-03734-6.html
   My bibliography  Save this article

Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease

Author

Listed:
  • Cameron S. McAlpine

    (Massachusetts General Hospital and Harvard Medical School
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Joseph Park

    (Massachusetts General Hospital and Harvard Medical School)

  • Ana Griciuc

    (Massachusetts General Hospital and Harvard Medical School)

  • Eunhee Kim

    (Massachusetts General Hospital and Harvard Medical School)

  • Se Hoon Choi

    (Massachusetts General Hospital and Harvard Medical School)

  • Yoshiko Iwamoto

    (Massachusetts General Hospital and Harvard Medical School)

  • Máté G. Kiss

    (Massachusetts General Hospital and Harvard Medical School)

  • Kathleen A. Christie

    (Massachusetts General Hospital and Harvard Medical School)

  • Claudio Vinegoni

    (Massachusetts General Hospital and Harvard Medical School)

  • Wolfram C. Poller

    (Massachusetts General Hospital and Harvard Medical School
    Icahn School of Medicine at Mount Sinai)

  • John E. Mindur

    (Massachusetts General Hospital and Harvard Medical School)

  • Christopher T. Chan

    (Massachusetts General Hospital and Harvard Medical School)

  • Shun He

    (Massachusetts General Hospital and Harvard Medical School)

  • Henrike Janssen

    (Massachusetts General Hospital and Harvard Medical School)

  • Lai Ping Wong

    (Massachusetts General Hospital
    Harvard Medical School)

  • Jeffrey Downey

    (Massachusetts General Hospital and Harvard Medical School)

  • Sumnima Singh

    (Massachusetts General Hospital and Harvard Medical School)

  • Atsushi Anzai

    (Massachusetts General Hospital and Harvard Medical School)

  • Florian Kahles

    (Massachusetts General Hospital and Harvard Medical School)

  • Mehdi Jorfi

    (Massachusetts General Hospital and Harvard Medical School)

  • Paolo Fumene Feruglio

    (University of Verona)

  • Ruslan I. Sadreyev

    (Massachusetts General Hospital
    Massachusetts General Hospital and Harvard Medical School)

  • Ralph Weissleder

    (Massachusetts General Hospital and Harvard Medical School)

  • Benjamin P. Kleinstiver

    (Massachusetts General Hospital and Harvard Medical School)

  • Matthias Nahrendorf

    (Massachusetts General Hospital and Harvard Medical School)

  • Rudolph E. Tanzi

    (Massachusetts General Hospital and Harvard Medical School)

  • Filip K. Swirski

    (Massachusetts General Hospital and Harvard Medical School
    Icahn School of Medicine at Mount Sinai)

Abstract

Communication within the glial cell ecosystem is essential for neuronal and brain health1–3. The influence of glial cells on the accumulation and clearance of β-amyloid (Aβ) and neurofibrillary tau in the brains of individuals with Alzheimer’s disease (AD) is poorly understood, despite growing awareness that these are therapeutically important interactions4,5. Here we show, in humans and mice, that astrocyte-sourced interleukin-3 (IL-3) programs microglia to ameliorate the pathology of AD. Upon recognition of Aβ deposits, microglia increase their expression of IL-3Rα—the specific receptor for IL-3 (also known as CD123)—making them responsive to IL-3. Astrocytes constitutively produce IL-3, which elicits transcriptional, morphological, and functional programming of microglia to endow them with an acute immune response program, enhanced motility, and the capacity to cluster and clear aggregates of Aβ and tau. These changes restrict AD pathology and cognitive decline. Our findings identify IL-3 as a key mediator of astrocyte–microglia cross-talk and a node for therapeutic intervention in AD.

Suggested Citation

  • Cameron S. McAlpine & Joseph Park & Ana Griciuc & Eunhee Kim & Se Hoon Choi & Yoshiko Iwamoto & Máté G. Kiss & Kathleen A. Christie & Claudio Vinegoni & Wolfram C. Poller & John E. Mindur & Christophe, 2021. "Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease," Nature, Nature, vol. 595(7869), pages 701-706, July.
    • Handle: RePEc:nat:nature:v:595:y:2021:i:7869:d:10.1038_s41586-021-03734-6
    DOI: 10.1038/s41586-021-03734-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-021-03734-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-021-03734-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jiyeon Lee & Haeryung Lee & Hyein Lee & Miram Shin & Min-Gi Shin & Jinsoo Seo & Eun Jeong Lee & Sun Ah Park & Soochul Park, 2023. "ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    2. Xingyu Zhang & Li Tang & Jiaolong Yang & Lanxia Meng & Jiehui Chen & Lingyan Zhou & Jiangyu Wang & Min Xiong & Zhentao Zhang, 2023. "Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    3. Timothy F. Shay & Seongmin Jang & Tyler J. Brittain & Xinhong Chen & Beth Walker & Claire Tebbutt & Yujie Fan & Damien A. Wolfe & Cynthia M. Arokiaraj & Erin E. Sullivan & Xiaozhe Ding & Ting-Yu Wang , 2024. "Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder," Nature Communications, Nature, vol. 15(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:595:y:2021:i:7869:d:10.1038_s41586-021-03734-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.